Pharmacological interventions to diminish cognitive side effects of electroconvulsive therapy: A systematic review and meta‐analysis
Open Access
- 8 February 2022
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 145 (4) , 343-356
Abstract
Objective: The authors conducted a systematic review and meta‐analysis of pharmacological interventions to diminish cognitive side effects of ECT.Methods: Electronic databases of Pubmed, PsycInfo, Embase and Scopus were searched from inception through 1 April, 2021, using terms for ECT (e.g. electroconvulsive therapy), cognitive outcome (e.g. cogni*) and pharmacological intervention (e.g. calcium channel blocker and general terms, like protein). Original studies with humans receiving ECT were included, which applied pharmacological interventions in comparison with placebo or no additive intervention to diminish cognitive side effects. Data quality was assessed using Risk of Bias and GRADE. Random‐effects models were used. PROSPERO registration number was CRD42021212773.Results: Qualitative synthesis (systematic review) showed 52 studies reporting sixteen pharmacological intervention‐types. Quantitative synthesis (meta‐analysis) included 26 studies (1387 patients) describing twelve pharmacological intervention‐types. Low‐quality evidence of efficacy was established for memantine (large effect size) and liothyronine (medium effect size). Very low‐quality evidence shows effect of acetylcholine inhibitors, piracetam and melatonin in some cognitive domains. Evidence of no efficacy was revealed for ketamine (very low‐quality), herbal preparations with anti‐inflammatory properties (very low to low‐quality) and opioid receptor agonists (low‐quality).Conclusion: Memantine and liothyronine are promising for further research and future application. Quality of evidence was low because of differences in ECT techniques, study populations and cognitive measurements. These findings provide a guide for rational choices of potential pharmacological intervention research targets to decrease the burden of cognitive side effects of ECT. Future research should be more uniform in design and attempt to clarify pathophysiological mechanisms of cognitive side effects of ECT.Keywords
This publication has 81 references indexed in Scilit:
- A Double-blind, Placebo-Controlled Study of the Impact of Galantamine on Anterograde Memory Impairment During Electroconvulsive TherapyThe Journal of ECT, 2013
- Comparison between the effect of liothyronine and piracetam on personal information, orientation and mental control in patients under treatment with ECTIndian Journal of Psychiatry, 2012
- Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapyBrain Stimulation, 2008
- Effect of Antidepressant Medication Resistance on Short-term Response to Electroconvulsive TherapyJournal of Clinical Psychopharmacology, 2004
- Patients' perspectives on electroconvulsive therapy: systematic reviewBMJ, 2003
- Lack of effect of 6 g inositol treatment on post-ECT cognitive function in humansJournal of Psychiatric Research, 1995
- Effects of Atropine and Glycopyrrolate on Cognitive Function Following Anaesthesia and Electroconvulsive Therapy (ECT)International Clinical Psychopharmacology, 1986
- Effects of Vasopressin on Human Memory FunctionsScience, 1981
- Effects of ACTH 4–10 on ECT‐induced memory dysfunctionsActa Psychiatrica Scandinavica, 1977
- “Mini-mental state”Journal of Psychiatric Research, 1975